EVOTAZ 300 mg/1 (Atazanavir and Cobicistat TABLET) 300 mg/1

EVOTAZ 300 mg/1 tablets combine atazanavir and cobicistat for HIV treatment. This prescription medication is designed to help manage HIV infection as part of a comprehensive treatment plan.

Strength

300 mg/1

Pack Size

30 TABLET in 1 BOTTLE (0003-3641-11)

Manufacturer / TM Owner

E.R. Squibb & Sons, L.L.C.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

EVOTAZ 300 mg/1 tablets are used in the treatment of HIV infection. This combination medication works by reducing the amount of HIV in the body, helping to improve immune function and reduce the risk of HIV-related complications. EVOTAZ is typically used alongside other antiretroviral drugs as part of a broader HIV treatment regimen. It is important to follow the advice of a healthcare provider when using this medication.

Side Effects

Common effects of EVOTAZ 300 mg/1 tablets may include nausea, headache, and dizziness. Some individuals may experience changes in skin color or jaundice. These effects vary among users and are not experienced by everyone. If any effects are severe or persistent, it is advisable to consult a healthcare professional.

Precautions & Warnings

EVOTAZ 300 mg/1 tablets should be handled with care. Store the medication in a cool, dry place away from direct sunlight. Keep the tablets out of reach of children and pets. Always follow the instructions provided by your healthcare provider regarding the use of this medication. Do not share this medication with others.

Avoid Interactions

EVOTAZ 300 mg/1 tablets can interact with other medications, including certain antibiotics, antifungals, and heart medications. It is important to inform your healthcare provider about all the medications you are taking before starting EVOTAZ. Avoid consuming alcohol while taking this medication, as it may increase the risk of side effects. Always consult a healthcare professional before starting any new medication.

Frequently Asked Questions

EVOTAZ 300 mg/1 tablets are used in the treatment of HIV infection as part of a comprehensive treatment plan.

Store EVOTAZ 300 mg/1 tablets in a cool, dry place away from direct sunlight and keep them out of reach of children and pets.

Common effects may include nausea, headache, dizziness, and changes in skin color or jaundice.

EVOTAZ 300 mg/1 tablets can interact with other medications, so it is important to consult a healthcare provider before combining them.

It is advisable to avoid alcohol while taking EVOTAZ 300 mg/1 tablets, as it may increase the risk of side effects.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.